Drug intelligence / Profile preview

Jiuwei Qingpeng San

Development stage: Unknown
Lead developer: Xizang Ganlu Tibetan Medicine
Modality: Small Molecules
Administration: Oral

Overview

Jiuwei Qingpeng San is a traditional Tibetan herbal medicine developed and manufactured by Xizang Ganlu Tibetan Medicine. It is an oral powder formulation composed of nine distinct herbal ingredients, typically including *Aconitum pendulum*, *Terminalia chebula*, and *Terminalia bellirica*. In the context of Tibetan medicine, it is primarily indicated for the treatment of "Chu-ser" (yellow fluid) diseases, which correspond to clinical conditions such as rheumatoid arthritis, gout, joint swelling, and muscle pain. The medicine is recognized for its anti-inflammatory and analgesic properties. It is an approved pharmaceutical product in China, holding a National Drug License Number (e.g., Z54020048).

Brand names: Ganlu
Other names: 九味青鹏散Jiuwei Qingpeng Powder

Beyond the preview

Go deeper on Jiuwei Qingpeng San.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiuwei Qingpeng San.

Explore the full profile